Vanda Pharmaceuticals Inc. VNDA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2006-04-12
Vanda Pharmaceuticals Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 8,138,252 | $46.0M |
| RENAISSANCE TECHNOLOGIES LLC | 3,759,559 | $26.0M |
| MILLENNIUM MANAGEMENT LLC | 1,881,001 | $13.0M |
| AQR CAPITAL MANAGEMENT LLC | 1,603,576 | $11.1M |
| TWO SIGMA INVESTMENTS, LP | 1,398,201 | $9.7M |
| CITADEL ADVISORS LLC | 825,254 | $5.7M |
| Point72 Asset Management, L.P. | 161,596 | $1.1M |
Source: SEC EDGAR filings · CIK 0001347178 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.